New study rewrites textbook on key genetic phenomenon

July 1, 2009

Because females carry two copies of the X chromosome to males' one X and one Y, they harbor a potentially toxic double dose of the over 1000 genes that reside on the X chromosome.

To compensate for this imbalance, mammals such as mice and humans shut down one entire through a phenomenon known as X-inactivation. For almost two decades, researchers have believed that one particular gene, called Xist, provides the molecular trigger of X-inactivation.

Now, a new UNC study appearing online July 1 in the journal Nature disputes the current dogma by showing that this process can occur even in the absence of this gene.

"Our study contradicts what is written in the textbooks," said senior study author Terry Magnuson, Ph.D., Sarah Graham Kenan Professor and chair of genetics, director of the Carolina Center for Genome Sciences and a member of the UNC Lineberger Comprehensive Cancer Center. "Everybody thought that Xist triggers X-inactivation, but now we have to rethink how this important process starts."

Previous studies showed that the Xist gene was active or "turned on" early in the course of X-inactivation and that disruptions in the gene resulted in irregular X-inactivation, eventually leading to the accepted assumption that Xist was the trigger. But it wasn't clear in the literature if this genetic phenomenon would initiate if Xist isn't present, said lead study author Sundeep Kalantry, Ph.D., postdoctoral fellow in the UNC department of genetics.

Kalantry used three different molecular techniques to look at X-inactivation in the of mice that were genetically engineered to contain a defective Xist gene on their future inactive X-chromosome. He discovered that the on this X-chromosome could be silenced regardless of whether they produced Xist. But while Xist was not absolutely required to start X-inactivation, without it genes along the X-chromosome eventually became active again. Thus, Xist appears to stabilize silencing of the X-chromosome over the long term.

Unlike most genes, the Xist gene doesn't code for a protein. Rather, it acts at the level of RNA - a copy of the DNA genetic sequence - which serves to recruit protein complexes through a process known as epigenetics. These proteins then form a molecular scaffold along the inactive-X chromosome that can stably silence the genes contained within it. The UNC researchers are now actively investigating how this chromosomal remodeling begins in the first place.

"If we can figure out the mechanism that triggers X-inactivation, we can potentially apply this knowledge to diseases that have an epigenetic component," Kalantry said. "So it can have implications not only in fundamentally understanding X-inactivation but also to gain insight into the increasing array of illnesses where the epigenetic machinery has gone awry - such as in prostate and breast cancers."

Source: University of North Carolina School of Medicine (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4 /5 (2 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • superhuman - Jul 01, 2009
    • Rank: not rated yet
    This study (at least as reported here) does not contradict the previous knowledge, to do this you have to show that Xist does not trigger X inactivation.

    Instead the authors showed that when there is no Xist inactivation will be triggered anyway and that Xist is also necessary at a later stage. This does not contradict the previous findings, many biological processes are robust and will proceed even if some players are absent.

July 1, 2009 all stories

Comments: 1

4 /5 (2 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 36 minutes ago | popularity not rated yet | comments 0

A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal Science Translational Medicine.


Scientists report first effective medical therapy for rare stomach disorder

Medicine & Health / Cancer

created 5 minutes ago | popularity not rated yet | comments 0

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.


CDC: Swine flu vaccine safe; no big problems seen

Medicine & Health / Medications

created 21 minutes ago | popularity not rated yet | comments 0

(AP) -- U.S. health officials say there's no evidence that the swine flu vaccine is causing any serious side effects.


First 'genetic map' of Han Chinese may aid search for disease susceptibility genes

Medicine & Health / Genetics

created 38 minutes ago | popularity not rated yet | comments 0

The first genetic historical map of the Han Chinese, the largest ethnic population in the world, as they migrated from south to north over evolutionary time. was published online today by the American Journal of Human Ge ...


Medical students regularly stuck by needles, often fail to report injuries

Medicine & Health / Other

created 44 minutes ago | popularity not rated yet | comments 0

Medical students are commonly stuck by needles -- putting them at risk of contracting potentially dangerous blood-borne diseases -- and many of them fail to report the injuries to hospital authorities, according to a Johns ...